What did @marleemichele actually say?
She didn't make a lot of clinical claims. What she did was document the experience of getting a testosterone pellet implant in real time, and her honest reaction was anxiety. She mentioned receiving antibiotics beforehand, noted the procedure involves an incision, and said she was about to receive numbing shots. Her bottom line: "this is a lot more intense than anticipated." That's not a medical claim, that's a patient being candid, and it's more useful than most pellet content on TikTok.
The hashtags do some heavier lifting than the transcript. Tags like bioidenticalhormonetherapy and pelletimplant attach her video to a broader ecosystem of wellness marketing that often overpromises. The video itself, though, stays grounded in the physical reality of the procedure.
Does the science back this up?
Her surprise at the procedure's intensity is well-founded. Testosterone pellet implantation is a minor surgical procedure, not a simple injection, and the complication profile reflects that. A 2019 study by Rao et al. in the Journal of Sexual Medicine found pellet extrusion rates between 1.9% and 8.6%, with infection occurring in roughly 0.6% to 1.1% of cases. Those numbers aren't alarming, but they aren't trivial either.
Prophylactic antibiotics before pellet insertion are standard practice at many clinics, consistent with general wound infection prevention guidance from the CDC's Surgical Site Infection recommendations. So the antibiotic she mentioned is clinically appropriate. The numbing shots she referenced are also standard, as the pellets are typically inserted subcutaneously in the upper buttock area via a small trocar incision under local anesthetic.
What the science is less settled on is whether pellets offer meaningful advantages over other testosterone delivery methods. A 2020 review by Khera in Translational Andrology and Urology noted that pellets produce supraphysiologic testosterone peaks early after insertion, which can be difficult to manage if a patient has side effects, because you cannot remove the pellet easily once it's in.
What did they get wrong (or right)?
She got the vibe right. Patients who go into pellet procedures expecting something close to a standard injection are often caught off guard, and her honest reaction helps set realistic expectations for viewers. That's genuinely valuable. Credit where it's due.
What she didn't address, and what the surrounding hashtag culture almost never addresses, is the lack of FDA approval specifically for pellet testosterone products. The FDA has approved testosterone in other forms, but subcutaneous pellets marketed under the "bioidentical" umbrella are largely compounded products. Compounded testosterone pellets are not equivalent to FDA-approved formulations in terms of verified dosing accuracy. A 2017 analysis by Pinkerton et al. in Menopause found significant variability in compounded hormone products, raising real quality-control questions. That's not a minor asterisk.
The term "bioidentical" itself deserves skepticism. It's a marketing term, not a pharmacological classification recognized by the FDA or most major medical societies.
What should you actually know?
If you're considering testosterone pellets, a few things matter more than any TikTok video. First, pellet insertion is an outpatient surgical procedure with real, if low, complication risks including infection, extrusion, and scarring. Antibiotics and local anesthesia are standard, not signs something is wrong.
Second, once a pellet is inserted, you're committed to whatever dose was implanted for roughly three to six months. If your levels run too high or you experience side effects, you cannot simply stop or reduce, unlike with gels or injections. This is a meaningful clinical tradeoff that deserves a serious conversation with a licensed provider before the procedure, not after.
Third, ask your provider whether the pellets being used are compounded or FDA-approved, and request documentation of third-party testing for potency and sterility. The Endocrine Society and ACOG have both noted insufficient evidence to recommend compounded bioidentical hormones over regulated alternatives. That doesn't mean pellets don't work for some patients, but it does mean the marketing around them often outruns the evidence.